Profound Medical Corp. PROF
Set alert
6.73 USD +0.16 +2.44%
At close · Nov 2
6.73 0.00 0.00%
After hours · Nov 2, 4:00 PM ET
6.51 Day range 7.11
5.06 52-week range 8.65
- YTD
- -14.49%
- 1 year
- +10.87%
- Open
- 6.51
- Prev close
- 6.57
- Mkt cap
- 245.92M
- Vol
- 290.36K
- Avg vol
- 192.57K
- EPS
- -1.01
- P/E
- 0.00
- Div yield
- 0.00%
More statistics
- Low
- 6.51
- High
- 7.11
- Forward P/E
- -7.95
- Beta
- 0.83
- Short ratio
- 7.87
- Inst. own
- 35.99%
- Dividend
- 0.00
- Ex-div date
- Earnings
- Aug 8, 2024
- 50-d avg
- 7.73
- 200-d avg
- 8.29
- 1y target
- 15.30
1Y chart
Signals (73)
| Name | Date | Ago |
|---|---|---|
| SMA: Bullish | Nov 2, 2026 | 18 hours ago |
| SMA: Bullish | Oct 30, 2026 | 3 days ago |
| MACD: Buy Signal | Oct 30, 2026 | 3 days ago |
| MACD: Sell Signal | Oct 20, 2026 | 1 week ago |
| SMA: Bearish | Oct 15, 2026 | 2 weeks ago |
| SMA: Bearish | Oct 14, 2026 | 2 weeks ago |
| SMA: Bullish | Oct 8, 2026 | 3 weeks ago |
| SMA: Bullish | Oct 8, 2026 | 3 weeks ago |
| MACD: Buy Signal | Sep 30, 2026 | 1 month ago |
| RSI: Oversold | Sep 14, 2026 | 1 month ago |
| MACD: Sell Signal | Sep 10, 2026 | 1 month ago |
| RSI: Oversold | Sep 10, 2026 | 1 month ago |
| MACD: Buy Signal | Sep 9, 2026 | 1 month ago |
| SMA: Bearish | Aug 28, 2026 | 2 months ago |
| SMA: Bearish | Aug 27, 2026 | 2 months ago |
| SMA: Bullish | Aug 26, 2026 | 2 months ago |
| SMA: Bullish | Aug 26, 2026 | 2 months ago |
| SMA: Bearish | Aug 20, 2026 | 2 months ago |
| SMA: Bearish | Aug 20, 2026 | 2 months ago |
| SMA: Bullish | Aug 19, 2026 | 2 months ago |
Newest 20 of 73.
Analyst view
Consensus: strong buy
Strong buy
Price target (mean) 15.30 +127.3% upside
Now 6.73
- Target (low)
- 12.00
- Target (mean)
- 15.30
- Target (high)
- 18.00
Ratings (0m) 5 5 buy · 0 hold · 0 sell
- Strong buy0
- Buy5
- Hold0
- Sell0
- Strong sell0
Recommendation trend
- This month 5
- 1 month ago 6
- 2 months ago 5
- 3 months ago 7
Earnings and revenue estimates
Consensus for the coming quarters and fiscal years
| Period | EPS estimate | Low – high | Year ago | EPS growth | Revenue estimate | Revenue growth | Analysts |
|---|---|---|---|---|---|---|---|
| Current quarter | -0.345 | -0.39 – -0.30 | -0.42 | +17.9% | 6.04M | +123.2% | 4 |
| Next quarter | -0.28333 | -0.30 – -0.27 | -0.26 | -9.0% | 6.49M | +148.5% | 3 |
| Current year | -1.27 | -1.31 – -1.22 | -1.35 | +6.3% | 15.74M | +62.4% | 4 |
| Next year | -0.918 | -1.42 – -0.21 | -1.27 | +27.4% | 37.74M | +139.8% | 5 |
Upgrades and downgrades
The latest rating changes
| Date | Firm | Action | From | To |
|---|---|---|---|---|
| Jul 16, 2024 | Stifel | Upgrade | Hold | Buy |
| Mar 11, 2024 | Alliance Global Partners | Maintained | Buy | Buy |
| Mar 8, 2024 | Stifel | Maintained | Hold | Hold |
| Jan 4, 2024 | Alliance Global Partners | Maintained | Buy | Buy |
| Nov 28, 2023 | Stifel | Initiated | — | Hold |
| Aug 4, 2023 | Raymond James | Downgrade | Strong Buy | Outperform |
| May 11, 2023 | TD Cowen | Maintained | — | Outperform |
| May 11, 2023 | Alliance Global Partners | Maintained | — | Buy |
| Mar 21, 2023 | Jefferies | Downgrade | Buy | Equal-Weight |
| Nov 4, 2022 | Raymond James | Upgrade | Outperform | Strong Buy |
| Mar 7, 2022 | Cowen & Co. | Maintained | — | Outperform |
| Feb 22, 2022 | Raymond James | Downgrade | Strong Buy | Outperform |
| Sep 15, 2020 | Jefferies | Initiated | — | Buy |
| Sep 10, 2020 | Lake Street | Initiated | — | Buy |
| Apr 1, 2020 | Cowen & Co. | Initiated | — | Outperform |